Chassalia parvifolia

Chassalia parvifolia · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Chassalia parvifolia is a botanical species recognized for its unique chemical profile and potential biological significance. This plant is notably characterized by the presence of specific secondary metabolites known as Circulin A and Circulin B. Researchers often utilize these compounds when studying the plant's specialized properties. To harness these active constituents, the plant is frequently processed into a concentrated extract. Understanding these chemical components is essential for exploring the therapeutic possibilities of the species.

Quick facts
Synonyms
Psychotria Engleri
Common names
Not available
Family
Rubiaceae
Distribution
Asia-Temperate
Plant Parts
Not available

Classification

Common Names

Chassalia parvifolia is a botanical species that is recognized by various local and scientific identifiers. Within certain regional contexts, this plant is commonly referred to by the name keniankoralliterttu. Understanding these naming conventions helps researchers and enthusiasts connect the plant to its specific ecological heritage. Such relationships between scientific classification and common nomenclature provide essential clarity for documentation. Consequently, mastering these linguistic links is vital for anyone studying the diverse flora of the region.

Sources: Catalogue of Life (COL)

Synonyms

Chassalia parvifolia is a botanical species that is frequently identified by its alternative scientific name, Psychotria engleri. This taxonomic synonym highlights the complex history of classification within the plant kingdom. Researchers often encounter both names when studying the specific characteristics of this particular specimen. Understanding these nomenclatural links is essential for accurate botanical identification and documentation. Consequently, recognizing the relationship between these two names ensures clarity in scientific communication.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Chassalia parvifolia belongs to the vast kingdom Plantae, representing the diverse world of multicellular organisms. Within this biological realm, it is classified under the class Equisetopsida. This plant is a member of the order Gentianales, which connects it to a specific group of flowering species. It further falls under the family Rubiaceae, a group known for many economically important plants. Finally, its taxonomic identity is defined by its placement within the genus Chassalia.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Gentianales
Family Rubiaceae
Genus Chassalia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Chassalia parvifolia is a plant species with a widespread presence across the African continent. Its distribution is notably concentrated within the diverse ecosystems of East Tropical Africa, specifically throughout Kenya and Tanzania. Furthermore, the species extends its reach into the landscapes of South Tropical Africa. In this southern region, it can be found thriving in Malawi, Mozambique, and Zambia. This broad geographical range highlights the adaptability of the plant within various African environments.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Chassalia parvifolia grows in a sturdy shrub form that provides a lush, textured appearance to its environment. As a self-supporting plant, it maintains its own structure and upright posture without the need for external assistance.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Chassalia parvifolia is a tropical tree that serves as a significant natural source of unique bioactive compounds. Within this plant, researchers have identified two specific macrocyclic peptides known as Circulin A and Circulin B. These molecules are particularly notable for their demonstrated ability to display anti-HIV activity. Because of their complex structures, which include six disulfide-linked cysteines, they have required advanced analytical techniques to fully understand. The discovery of these circulins within the plant highlights the medicinal potential held by the species.

Conditions

Chassalia parvifolia contains macrocyclic peptides known as circulins that possess significant anti-HIV activity. These compounds, specifically circulin A and B, demonstrate the ability to inhibit the virus through their unique disulfide linkage patterns. Furthermore, the plant yields other macrocyclic polypeptides, such as circulins C-F, which effectively treat the cytopathic effects of in vitro HIV-1 infection. These specific peptides show potent inhibitory capabilities with EC(50) values ranging from 50 to 275 nM. Consequently, the chemical constituents of Chassalia parvifolia serve as vital agents in combating the cellular damage caused by HIV-1.

Preparations

Chassalia parvifolia is prepared as an extract to facilitate the isolation of specific bioactive compounds. From this botanical extract, researchers successfully identified four new macrocyclic polypeptides known as circulins C-F. These unique peptides are characterized by a primary amino acid chain that is covalently cyclized through peptide bonds. The structural complexity of these molecules is further defined by six cysteine residues that form three intramolecular disulfide bridges. Ultimately, the components derived from this plant extract demonstrate significant potential by inhibiting the cytopathic effects of HIV-1 infection.

Parts used